Kern, David M <br/><br/>
A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease.  [electronic resource] 

 -  International journal of chronic obstructive pulmonary disease  2014 
 - 775-83 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1178-2005 
<br/><br/><label>Standard No.: </label>10.2147/COPD.S64491  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-2 Receptor Agonists--adverse effects<br/>Adult<br/>Age Factors<br/>Aged<br/>Bronchodilator Agents--adverse effects<br/>Budesonide--adverse effects<br/>Chi-Square Distribution<br/>Cholinergic Antagonists--adverse effects<br/>Comorbidity<br/>Cross-Sectional Studies<br/>Data Mining<br/>Databases, Factual<br/>Drug Combinations<br/>Drug Costs<br/>Ethanolamines--adverse effects<br/>Female<br/>Formoterol Fumarate<br/>Glucocorticoids--adverse effects<br/>Health Expenditures<br/>Humans<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Scopolamine Derivatives--adverse effects<br/>Sex Factors<br/>Time Factors<br/>Tiotropium Bromide<br/>Treatment Outcome<br/>United States--epidemiology